Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Abbott Laboratories for $19.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Abbott Laboratories (ABT)


Price to FCFE (P/FCFE)

Intermediate level


Free Cash Flow to Equity (FCFE)

Abbott Laboratories, FCFE calculation

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net earnings hidden hidden hidden hidden hidden
Net noncash charges hidden hidden hidden hidden hidden
(Increase) decrease in operating capital hidden hidden hidden hidden hidden
Net cash from operating activities hidden hidden hidden hidden hidden
Acquisitions of property and equipment hidden hidden hidden hidden hidden
Proceeds from issuance (repayments) of short-term debt and other hidden hidden hidden hidden hidden
Proceeds from issuance of long-term debt and debt with maturities over 3 months hidden hidden hidden hidden hidden
Repayments of long-term debt and debt with maturities over 3 months hidden hidden hidden hidden hidden
Payment of bridge financing fees hidden hidden hidden hidden hidden
Free cash flow to equity (FCFE) hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

Item Description The company
FCFE Free cash flow to equity is the cash flow available to Abbott Laboratories’s equity holders after all operating expenses, interest, and principal payments have been paid and necessary investments in working and fixed capital have been made. Abbott Laboratories’s FCFE decreased from 2016 to 2017 and from 2017 to 2018.

Price to FCFE Ratio, Current

Abbott Laboratories, current P/FCFE calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
No. shares of common stock outstanding hidden
Selected Financial Data (US$)
Free cash flow to equity (FCFE) (in millions) hidden
FCFE per share hidden
Current share price (P) hidden
Valuation Ratio
P/FCFE hidden
Benchmarks
P/FCFE, Competitors1
AbbVie Inc. hidden
Allergan PLC hidden
Amgen Inc. hidden
Biogen Inc. hidden
Bristol-Myers Squibb Co. hidden
Eli Lilly & Co. hidden
Gilead Sciences Inc. hidden
Johnson & Johnson hidden
Merck & Co. Inc. hidden
Pfizer Inc. hidden
Regeneron Pharmaceuticals Inc. hidden
P/FCFE, Sector
Pharmaceuticals & Biotechnology hidden
P/FCFE, Industry
Health Care hidden

Based on: 10-K (filing date: 2019-02-22).

1 Click competitor name to see calculations.

If the company P/FCFE is lower then the P/FCFE of benchmark then company is relatively undervalued.
Otherwise, if the company P/FCFE is higher then the P/FCFE of benchmark then company is relatively overvalued.


Price to FCFE Ratio, Historical

Abbott Laboratories, historical P/FCFE calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
No. shares of common stock outstanding1 hidden hidden hidden hidden hidden
Selected Financial Data (US$)
Free cash flow to equity (FCFE) (in millions)2 hidden hidden hidden hidden hidden
FCFE per share3 hidden hidden hidden hidden hidden
Share price1, 4 hidden hidden hidden hidden hidden
Valuation Ratio
P/FCFE5 hidden hidden hidden hidden hidden
Benchmarks
P/FCFE, Competitors6
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
P/FCFE, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
P/FCFE, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

1 Data adjusted for splits and stock dividends.

2 See details »

3 2018 Calculation
FCFE per share = FCFE ÷ No. shares of common stock outstanding
= hidden ÷ hidden = hidden

4 Closing price as at the filing date of Abbott Laboratories’s Annual Report.

5 2018 Calculation
P/FCFE = Share price ÷ FCFE per share
= hidden ÷ hidden = hidden

6 Click competitor name to see calculations.

Valuation ratio Description The company
P/FCFE Price to free cash flow to equity is cash valuation indicator of stockholders’ equity. Abbott Laboratories’s P/FCFE ratio increased from 2016 to 2017 but then decreased significantly from 2017 to 2018.